Evaluation of Clinical Impacts and Costs of eHealth in Rwanda

NAUnknownINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

September 15, 2018

Primary Completion Date

July 15, 2020

Study Completion Date

July 30, 2020

Conditions
HIV/AIDS and InfectionsElectronic Medical RecordsClinical Decision Support System
Interventions
OTHER

Experimental: Intervention 1 (Int1)

This intervention will consist of the following additions to the EMR package. A link on the clinician's homepage to enrol a new HIV+ patient in the EMR which will open a form for (1) entering patient demographics (2) adding the contact home address or description of area, phone number (if available), (3) the peer educator contacts (4) recording the HIV+ result and date. A report will be added that is run every week to identify HIV+ patients not linked to care. The patients identified will be checked with paper records to ensure they have definitely not visited, then contacted after one, 2 weeks and 4 weeks if he/she did not show up. After two attempted contacts, if the patient is not yet linked to care he/she will be visited at home by the health facility social worker using routine home visits by health care providers.

OTHER

Experimental: Intervention 2 (Int2)

The data on availability of VL results in the EMR will come from a SQL statement to query the OpenMRS database. An alert will be fired if the patient has been enrolled for 8 months or more and does not have a viral load result in the EMR. The alert will be displayed on the patient summary and on the consult sheets, with text requesting the clinician orders a VL.

OTHER

Experimental: Intervention 3 (Int3)

The data on VL results in the EMR showing detectable virus will come from a SQL statement to query the OpenMRS database. An alert will be fired if the patient has been enrolled for at least 12 months and the VL result in the EMR shows \> 1000 copies/mm3. The alert will be displayed on the patient summary and on the consult sheets requesting actions to address treatment failure (change first line medication, start second line medication, repeat VL, counselling on treatment adherence). A report will also be added to regularly check for patients with high viral load.

Trial Locations (1)

250

School of Public Health, Kigali

Sponsors
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Ministry of Health, Rwanda

OTHER_GOV

collaborator

Rwanda Biomedical Centre

OTHER

collaborator

Partners in Health

OTHER

collaborator

Innovative Support to Emergencies Diseases and Disasters

UNKNOWN

collaborator

University of Pittsburgh

OTHER

collaborator

Jembi Health Systems

UNKNOWN

collaborator

Brown University

OTHER

lead

National University, Rwanda

OTHER

NCT04283929 - Evaluation of Clinical Impacts and Costs of eHealth in Rwanda | Biotech Hunter | Biotech Hunter